secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001641172-25-015115
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos closes $6M+stock acquisition of Sleep Center of Nevada; secures $11M+ financing
--------------------------------------------------------------------------------

- Acquired SCN for $6M cash + $1.5M in stock (607,287 shares) + assumption of liabilities; up to $1.5M earn-out in stock.
- Senior secured loan of $8.25M from Streeterville Capital (9% interest, 18-month maturity) netted $7.5M to Vivos.
- PIPE from New Seneca affiliate: 828K shares, pre-funded warrant for 725K shares, and 5-yr warrant for 2.33M shares at $2.23; total gross ~$3.755M.
- SCN sees ~3,000 new patients/month, annual high-seven-figure revenue; 90% test positive for OSA; Vivos expects to add diagnostic/appliance revenue over 12-18 months.
- Board-certified sleep specialists Dr. Prabhu Rachakonda and Dr. Tara Rachakonda join Vivos; continue practice management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000164117225015115/0001641172-25-015115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000164117225015115/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer